Información de la revista
Vol. 34. Núm. 1.Enero 2014
Páginas 0-138
Vol. 34. Núm. 1.Enero 2014
Páginas 0-138
Acceso a texto completo
Peritonitis asociada a la diálisis peritoneal, 27 años de experiencia en un único centro, Medellín, Colombia
Peritoneal dialysis-related peritonitis: twenty-seven years of experience in a Colombian medical center
Visitas
11590
John F. Nieto-Ríosa, James S. Díaz-Betancurb, Mario Arbeláez-Gómezc, Álvaro García-Garcíac, Joaquín Rodelo-Ceballosc, Alberto Reino-Buelvasc, Lina M. Serna-Higuitaa, Jorge E. Henao-Sierrac
a Servicio de Nefrología, Hospital Pablo Tobón Uribe, Medellín, Antioquia, Colombia,
b Servicio de Medicina Interna, Hospital San Vicente de Paúl, Medellín, Antioquia, Colombia,
c Servicio de Nefrología, Hospital San Vicente de Paúl, Medellín, Antioquia, Colombia,
Este artículo ha recibido
Información del artículo

Desde que se implementó por primera vez, la peritonitis ha sido la complicación más común de la diálisis peritoneal ambulatoria continua (DPAC) y sigue siendo la causa principal del fracaso del tratamiento y del cambio a otros tratamientos renales sustitutivos. En este estudio se presenta una serie colombiana de un total de 2469 episodios de peritonitis en 914 pacientes de una cohorte de 1497 pacientes en diálisis peritoneal (DP), que fueron sometidos a seguimiento durante casi tres décadas en un único centro. Se trata de la mayor serie de Latinoamérica de pacientes con peritonitis asociada con DP. Objetivo: Describir la peritonitis asociada con la DPAC en una cohorte de pacientes sometidos a seguimiento durante 27 años en un único centro y comparar los resultados con los observados en otras partes del mundo. Diseño del estudio: Estudio prospectivo de pacientes incidentes de DPAC desde marzo de 1981 hasta diciembre de 2008. Resultados: En nuestro centro, la tasa de peritonitis ha permanecido estable entre 0,8 y 0,9 desde 1981 y no se han observado cambios significativos en los 27 años de seguimiento. La tasa es similar a la descrita actualmente por otros grandes centros de diálisis del mundo, que han registrado importantes mejoras en las últimas décadas. No se detectaron diferencias significativas en las muestras aisladas de microorganismos gram positivos o gram negativos u hongos en lo que respecta a los registrados en otras grandes series ni en la frecuencia de peritonitis con cultivo negativo. Conclusión: En este estudio se presenta la mayor serie de Latinoamérica de pacientes con peritonitis asociada con DPAC con un total de 2469 pacientes. La tasa de peritonitis asociada con DPAC permaneció prácticamente inalterable durante las tres décadas de observación, a pesar de haber utilizado tres sistemas diferentes de DPAC. Nuestra hipótesis es que las condiciones socioeconómicas de los pacientes ingresados para diálisis peritoneal influyen en la tasa de peritonitis.

 

Palabras clave:
Latinoamérica
Palabras clave:
Colombia
Palabras clave:
Diálisis peritoneal
Palabras clave:
Peritonitis

Peritonitis has been the most common complication of continues ambulatory peritoneal dialysis (CAPD) since it was first implemented, and it remains the leading cause of treatment failure and transfer to other renal replacement therapies. This study presents a Colombian series with a total of 2,469 episodes of peritonitis in 914 patients from a cohort of 1,497 patients on PD, who were followed for almost three decades at a single center. This is the largest Latin American series of patients with PD-related peritonitis. Objective: To describe the CAPD-related peritonitis in a cohort of patients followed for 27 years at a single center, and compare the results with those observed elsewhere in the world. Study Design: Prospective study of incident patients on CAPD from March 1981 to December 2008. Results: In our center, the rate of peritonitis has been steady between 0.8 and 0.9 since 1981 and no significant changes have been noticed in the 27 years of follow up. The rate remains similar to that described nowadays by other large dialysis centers in the world, which have reported significant improvements in recent decades. No significant differences were found in the isolates of gram-positive and gram-negative microorganisms or fungi with respect to those reported by other large series, or in the frequency of culture-negative peritonitis. Conclusion: This study presents the largest Latin American series of patients with CAPD-related peritonitis with a total of 2,469 patients. In this study, the rate of CAPD-related peritonitis remained almost the same during the three decades of observation despite having used three different CAPD systems. Our hypothesis is that the socio-economic conditions of the patients admitted for peritoneal dialysis influences the rate of peritonitis.

Keywords:
Latin America
Keywords:
Colombia
Keywords:
Peritoneal dialysis
Keywords:
Peritonitis
El Texto completo está disponible en PDF
Bibliografía
[1]
Voinescu CG, Khanna R. Peritonitis in peritoneal dialysis. Int J Artif Organs 2002;25(4):249-60. [Pubmed]
[2]
Stablein DM, Nolph KD, Lindblad AS. Timing and characteristics of multiple peritonitis episodes: a report of the National CAPD Registry. Am J Kidney Dis 1989;14(1):44-9. [Pubmed]
[3]
Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006;(103):S55-62.
[4]
Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996;7(10):2176-82. [Pubmed]
[5]
Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005;25(2):107-31. [Pubmed]
[6]
Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int 1992;42(4):967-74. [Pubmed]
[7]
Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, et al. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004;24(5):424-32. [Pubmed]
[8]
Oo TN, Roberts TL, Collins AJ. A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis 2005;45(2):372-80. [Pubmed]
[9]
Kan GW, Thomas MA, Heath CH. A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients? Perit Dial Int 2003;23(5):465-8. [Pubmed]
[10]
Kavanagh D, Prescott GJ, Mactier RA. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 2004;19(10):2584-91. [Pubmed]
[11]
Daly CD, Campbell MK, MacLeod AM, Cody DJ, Vale LD, Grant AM, et al. Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 2001;16(2):341-7. [Pubmed]
[12]
Harris DC, Yuill EJ, Byth K, Chapman JR, Hunt C. Twin- versus single-bag disconnect systems: infection rates and cost of continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996;7(11):2392-8. [Pubmed]
[13]
Li PK, Szeto CC, Law MC, Chau KF, Fung KS, Leung CB, et al. Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study. Am J Kidney Dis 1999;33(3):535-40. [Pubmed]
[14]
Kiernan L, Kliger A, Gorban-Brennan N, Juergensen P, Tesin D, Vonesh E, et al. Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems. J Am Soc Nephrol 1995;5(10):1835-8. [Pubmed]
[15]
Monteon F, Correa-Rotter R, Paniagua R, Amato D, Hurtado ME, Medina JL, et al. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. The Mexican Nephrology Collaborative Study Group. Kidney Int 1998;54(6):2123-8.
[16]
Tielens E, Nube MJ, de Vet JA, van Limbeek J, Hofman X, Steffens A, et al. Major reduction of CAPD peritonitis after the introduction of the twin-bag system. Nephrol Dial Transplant 1993;8(11):1237-43. [Pubmed]
[17]
Owen JE, Walker RG, Lemon J, Brett L, Mitrou D, Becker GJ. Randomized study of peritonitis with conventional versus O-set techniques in continuous ambulatory peritoneal dialysis. Perit Dial Int 1992;12(2):216-20. [Pubmed]
[18]
Moraes TP, Pecoits-Filho R, Ribeiro SC, Rigo M, Silva MM, Teixeira PS, et al. Peritoneal dialysis in Brazil: twenty-five years of experience in a single center. Perit Dial Int 2009;29(5):492-8. [Pubmed]
[19]
Bevilacqua JL, Marabezi MGB, Caniello CA, Camargo MC, Neves AV, Gomes JG. Diálise peritoneal contínua ambulatorial (DPAC): experiência de 10 anos de um centro brasileiro. Jornal Brasileiro Nefrologia 1995;17:206-13.
[20]
Figueiredo AE, Poli de Figueiredo CE, d'Avila DO. Bag exchange in continuous ambulatory peritoneal dialysis without use of a face mask: experience of five years. Adv Perit Dial 2001;17:98-100. [Pubmed]
[21]
Figueiredo AE, Poli de Figueiredo CE, d'Avila DO. Peritonitis prevention in CAPD: to mask or not? Perit Dial Int 2000;20(3):354-8. [Pubmed]
[22]
Concha S, Mejía O. La influencia de los episodios de peritonitis en un programa de diálisis peritoneal ambulatorio continua (DPAC). Acta Med Colomb 1995;20:31-42.
[23]
Restrepo CA. Treatment of bacterial peritonitis with once-daily dose of intraperitoneally antibiotics. Acta Med Colomb 2006;31(3):97-103.
[24]
Oreopoulos DG, Robson M, Izatt S, Clayton S, deVeber GA. A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 1978;24:484-9. [Pubmed]
[25]
Bazzato G, Landini S, Coli U, Lucatello S, Fracasso A, Moracchiello M. A new technique of continuous ambulatory peritoneal dialysis (CAPD): double-bag system for freedom to the patient and significant reduction of peritonitis. Clin Nephrol 1980;13(6):251-4. [Pubmed]
[26]
Wong HS, Ong LM, Lim TO, Hooi LS, Morad Z, Ghazalli R, et al. A randomized, multicenter, open-label trial to determine peritonitis rate, product defect, and technique survival between ANDY-Disc and UltraBag in patients on CAPD. Am J Kidney Dis 2006;48(3):464-72. [Pubmed]
[27]
Keane W, Bailie G, Boeschoten E, Gokal R, Golper T, Holmes C, et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 2000;20(4):396-411. [Pubmed]
[28]
Brown F, Liu WJ, Kotsanas D, Korman TM, Atkins RC. A quarter of a century of adult peritoneal dialysis-related peritonitis at an Australian medical center. Perit Dial Int 2007;27(5):565-74. [Pubmed]
[29]
Ghali JR, Bannister K, Brown FG, Rosman J, Wiggins K, Johnson DW, et al. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int 2011;31(6):651-62. [Pubmed]
[30]
Mahmoud KM, Sheashaa HA, Gheith OA, Wafa EW, Agroudy AE, Sabry AA, et al. Continuous ambulatory peritoneal dialysis in Egypt: progression despite handicaps. Perit Dial Int 2010;30(3):269-73. [Pubmed]
[31]
Suhardjono. The development of a continuous ambulatory peritoneal dialysis program in Indonesia. Perit Dial Int 2008;28 Suppl 3:S59-62. [Pubmed]
[32]
Elhassan EA, Kaballo B, Fedail H, Abdelraheem MB, Ali T, Medani S, et al. Peritoneal dialysis in the Sudan. Perit Dial Int 2007;27(5):503-10. [Pubmed]
[33]
Van Bui P. How peritoneal dialysis has developed in Vietnam. Perit Dial Int 2008;28 Suppl 3:S63-6. [Pubmed]
[34]
Martin L, Caramori J, Fernandes F, Divino-Filho JC, Pecoits-Filho R, Barretti P, Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol 2011;6:1944-51. [Pubmed]
[35]
Holley JL, Bernardini J, Perlmutter JA, Piraino B. A comparison of infection rates among older and younger patients on continuous peritoneal dialysis. Perit Dial Int 1994;14(1):66-9. [Pubmed]
[36]
Viglino G, Cancarini GC, Catizone L, Cocchi R, De Vecchi A, Lupo A, et al. Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Italian Cooperative Peritoneal Dialysis Study Group. Nephrol Dial Transplant 1994;9(10):1443-8.
[37]
Chow KM, Szeto CC, Leung CB, Law MC, Li PK. Impact of social factors on patients on peritoneal dialysis. Nephrol Dial Transplant 2005;20(11):2504-10. [Pubmed]
[38]
Farias MG, Soucie JM, McClellan W, Mitch WE. Race and the risk of peritonitis: an analysis of factors associated with the initial episode. Kidney Int 1994;46(5):1392-6. [Pubmed]
[39]
Prowant BF. Nursing interventions related to peritonitis. Adv Ren Replace Ther 1996;3(3):237-9. [Pubmed]
[40]
Miller TE, Findon G. Touch contamination of connection devices in peritoneal dialysis--a quantitative microbiologic analysis. Perit Dial Int 1997;17(6):560-7. [Pubmed]
[41]
Hall G, Bogan A, Dreis S, Duffy A, Greene S, Kelley K, et al. New directions in peritoneal dialysis patient training. Nephrol Nurs J 2004;31(2):149-54, 159-63. [Pubmed]
[42]
Veron D, De Paulis A, Santoianni J, Zucchini A, Gutierrez M, Predari SC. Peritonitis in peritoneal dialysis. Ten years experience. XVth International Congress of Nephrology, May 2-6,1999; May 2-6, 1999; Buenos Aires, Argentina:ISN1999:1229.
[43]
Miorin LA, Gomes KS, Macedo CS, Saravia RM, Silva HGS, Sens YAS. Peritonite em diálise peritoneal continua¿relação com o estado de portador. XVIth Congresso Brasileiro de Nefrologia. Rio de Janeiro; 1992: 22.
[44]
Menezes JAV, Rocha MA, Gonçalves RV, Andrade ES, Maia AV, Mendes DGS. CAPD ¿ 9 anos de experiência na CDRNova Iguaçu ¿ RJ. Jornal Brasileiro Nefrologia 1998;XX:166-P395.
[45]
Silva MM, Pecoits-Filho R, Rocha CS, Stinghen AE, Pachaly MA, Nascimento MM, et al. The recommendations from the International Society for Peritoneal Dialysis for Peritonitis Treatment: a single-center historical comparison. Adv Perit Dial 2004;20:74-7. [Pubmed]
[46]
Breien Alcaráz HS, Rojas Lopez V, Loza Romero AE. Incidence of germs and their sensitivity: 444 cultures of peritoneal dialysis (PD) liquid [Abstract]. Perit Dial Int 2006;26 Suppl 1:S27.
[47]
Wanten GJ, Koolen MI, van Liebergen FJ, Jansen JL, Wever J. Outcome and complications in patients treated with continuous ambulatory peritoneal dialysis (CAPD) at a single centre during 11 years. Neth J Med 1996;49(1):4-12. [Pubmed]
[48]
Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000;36(5):1009-13. [Pubmed]
[49]
Korbet SM, Vonesh EF, Firanek CA. Peritonitis in an urban peritoneal dialysis program: an analysis of infecting pathogens. Am J Kidney Dis 1995;26(1):47-53. [Pubmed]
[50]
Finkelstein ES, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 2002;39(6):1278-86. [Pubmed]
[51]
Blunden M, Zeitlin D, Ashman N, Fan SL. Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes. Nephrol Dial Transplant 2007;22(6):1714-9. [Pubmed]
[52]
Prowant B, Nolph K, Ryan L, Twardowski Z, Khanna R. Peritonitis in continuous ambulatory peritoneal dialysis: analysis of an 8-year experience. Nephron 1986;43(2):105-9. [Pubmed]
Idiomas
Nefrología
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?